-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Revolution Medicines, Raises Price Target to $195

Benzinga·06/01/2026 17:03:54
Listen to the news
HC Wainwright & Co. analyst Robert Burns maintains Revolution Medicines (NASDAQ:RVMD) with a Buy and raises the price target from $169 to $195.